Brain-gut microbiome interactions and functional bowel disorders
Bibcode:2010PNAS..107..551S
GLP-1 Series Part 1: Utilization drives decline in DPP-4 inhibitors, increase in SGLT2s among competitive drug classes Contact sales for details
The term refers to the eating plan followed while taking GLP-1 agonist medications (like Ozempic & Wegovy), which mimic the GLP-1 hormone to slow digestion, reduce appetite, and increase fullness, leading to weight loss
Semaglutide combined with cagrilintide (1.2 mg and 2.4 mg) resulted in significantly greater weight loss (15.7% and 17.1%, respectively) at week 20 compared to semaglutide combined with placebo (9.8%) [123]
The GLP-1 ads quote a monthly price, but the psychological one is still unknown